Metastatic brain metastases associated with metastatic RCC reveal a response to Cabozantinib
Significant intracranial and extracranial responses have been reported with the use of cabozantinib (Cabometyx) in patients with metastatic renal cell carcinoma (RCC) and brain metastases.Results s…
